Business Standard

Analysts' corner

Dr Reddy's Labs & Indraprastha Gas

Related News

DR REDDY’S LABS
Reco price: Rs 1,709;
Target price: Rs 1,950
Dr Reddy’s (DRRD) has filed an abbreviated new drug application for singulair granules oral formulation, used for treatment of asthma in children. Innovator Merck has sued DRRD for infringement of a patent on this, which expires in October 2022. This product has $80 million annual sales in the US. DRRD can launch earliest in September 14, after expiry of a 30-month stay on generic launch. Mylan and Teva could be the first to file on this product. Overweight.

HSBC Global Research

INDRAPRASTHA GAS
Reco price: Rs 346;
Target price: Rs 426
The Petroleum and Natural Gas Regulatory Board (PNGRB) has issued an order on network rates and compression charge for (IGL);. Against IGL’s proposed Rs 7.8/scm of network rate and compression charge, the PNGRB has allowed a mere Rs 3.1/scm, a decline of Rs 4.7/scm. Even after allowing for a marketing margin over and above this (the quantum of which, however, is uncertain), the order comes as a significant negative surprise, leading to a potential downside of 45-65 per cent to Citigroup’s Ebitda. Under this scenario, IGL will struggle to make even normative returns on the capital it has invested in the business. Maintain buy.

Citigroup

Read more on:   
|

Read More

Axis Bank: Concerns reflect in valuations

Axis Bank posted good set of numbers for the quarter ended 31st March 2012, beating the consensus estimates. Higher than expected growth in interest ...

Quick Links

 

Market News

In which sectors do FIIs have the most leg room to invest?

Oil & Gas tops the list

Oil prices up on Ukraine tensions, rosy US data

The United States warned it was considering new sanctions against Russia over the latest development

Markets closed on account of Ganesh Chaturthi

The government will release GDP data for the first quarter later today

Sensex rises 47% since 52-week low

Improvement in earnings, govt policies could provide more legs to the rally that started a year ago

Axis Bank, Maruti Suzuki, L&T scrips more than double in a year

While the benchmark index has moved up 48% between 29 August 2013 till date; Axis Bank, Maruti Suzuki and Larsen and Toubro (L&T) have ...

Back to Top